These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 17130269
1. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients. Fernandez-Fresnedo G, Rodrigo E, de Francisco AL, de Castro SS, Castañeda O, Arias M. J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S246-9. PubMed ID: 17130269 [Abstract] [Full Text] [Related]
2. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Wang MC, Tsai WC, Chen JY, Huang JJ. Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271 [Abstract] [Full Text] [Related]
4. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G. Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656 [Abstract] [Full Text] [Related]
5. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients]. Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL. Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):753-9. PubMed ID: 15949381 [Abstract] [Full Text] [Related]
6. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients]. Grabysa R, Cholewa M. Pol Merkur Lekarski; 2008 Jun 23; 24(144):487-91. PubMed ID: 18702327 [Abstract] [Full Text] [Related]
7. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL. Am J Kidney Dis; 2009 Apr 23; 53(4 Suppl 4):S3-10. PubMed ID: 19285609 [Abstract] [Full Text] [Related]
8. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F. Nefrologia; 2008 Apr 23; 28 Suppl 3():39-48. PubMed ID: 19018737 [Abstract] [Full Text] [Related]
9. [Cardiovascular system in patients in different stages of chronic kidney disease]. Strózecki P, Kozłowski M, Grajewska M, Kurowski R, Stefańska A, Odrowaź-Sypniewska G, Serafin Z, Lasek W, Nartowicz E, Kubica J, Manitius J. Pol Merkur Lekarski; 2006 Aug 23; 21(122):125-9; discussion 130-1. PubMed ID: 17144094 [Abstract] [Full Text] [Related]
10. Cardiovascular disease in children with chronic renal failure. Flynn JT. Growth Horm IGF Res; 2006 Jul 23; 16 Suppl A():S84-90. PubMed ID: 16698298 [Abstract] [Full Text] [Related]
11. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Kendrick J, Chonchol MB. Nat Clin Pract Nephrol; 2008 Dec 23; 4(12):672-81. PubMed ID: 18825155 [Abstract] [Full Text] [Related]
12. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Roberts MA, Hare DL, Ratnaike S, Ierino FL. Am J Kidney Dis; 2006 Sep 23; 48(3):341-60. PubMed ID: 16931208 [Abstract] [Full Text] [Related]
13. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Isbel NM, Haluska B, Johnson DW, Beller E, Hawley C, Marwick TH. Am Heart J; 2006 Mar 23; 151(3):745-53. PubMed ID: 16504645 [Abstract] [Full Text] [Related]